Each measurement emphasizes a different physiological feature. Inhaled tracers indicate where ventilation occurs, blood-flow information shows whether gas-exchanging regions receive perfusion, and signal or anatomical changes during breathing reveal tissue motion. Considering these signals separately and together helps distinguish impaired airflow, altered regional blood delivery, and abnormal movement rather than reducing lung performance to one overall value.
Global tests summarize lung performance across the entire organ, so they can conceal localized abnormalities. Regional imaging shows where ventilation, perfusion, or tissue motion differs from surrounding areas. This spatial information can connect functional impairment with specific anatomical regions, supporting more informative disease assessment and helping researchers evaluate whether an intervention changes the affected portions of the lung.
Breathing provides a changing physiological reference for interpreting lung motion and signal variation. Measurements collected across the respiratory cycle can show how tissue movement and regional function change rather than providing only a static snapshot. This temporal perspective is important when linking anatomical structure to breathing mechanics and when building models that represent lung behavior under dynamic conditions.
Combining these dimensions allows researchers to compare how air delivery, blood supply, airway anatomy, and tissue movement relate within the same lung. A region may appear structurally different, function differently, or show a mismatch between those features. Such integrated interpretation provides a stronger basis for identifying regional abnormalities and connecting observed function with its underlying structure.
A general workflow begins by acquiring imaging measurements during breathing, then examining the resulting ventilation, perfusion, structural, or motion-related information. Researchers can organize these regional observations for comparison with computational models or other assessments. The resulting analysis supports interpretation of lung behavior, identification of abnormal patterns, and evaluation of how a therapy or device affects function.
It is particularly useful when overall respiratory measurements do not show where an abnormality occurs. Regional information can identify affected areas and relate them to airway structure, tissue motion, ventilation, or blood delivery. That added detail supports disease assessment and can inform treatment planning by showing how impairment is distributed rather than representing the lung as a single uniform system.
Bioengineers can use regional functional measurements to evaluate whether an engineered therapy or device produces meaningful changes in lung behavior. Imaging links intervention-related outcomes with ventilation, perfusion, tissue motion, or structure, while computational models help interpret those changes. This combination supports development of more precise pulmonary technologies and provides functional evidence beyond a global performance measure.